Darzalex combo wins nod for newly diagnosed multiple myeloma

8th May 2018 Uncategorised 0

Janssen’s Darzalex has become the first monoclonal antibody to be approved in the US to treat patients newly diagnosed with multiple myeloma.

More: Darzalex combo wins nod for newly diagnosed multiple myeloma
Source: News